sb 203580 has been researched along with nsc 664704 in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nsc 664704) | Trials (nsc 664704) | Recent Studies (post-2010) (nsc 664704) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 95 | 0 | 50 |
| Protein | Taxonomy | sb 203580 (IC50) | nsc 664704 (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8335 | |
| Cyclin-T1 | Homo sapiens (human) | 0.064 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.4 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.47 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.4 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.4243 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.4243 | |
| Cyclin-A2 | Homo sapiens (human) | 0.73 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.73 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 9 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.023 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0657 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.064 | |
| Cyclin-A1 | Homo sapiens (human) | 0.73 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.6314 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.6314 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.4 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.4243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Laufer, S; Pillaiyar, T | 1 |
1 review(s) available for sb 203580 and nsc 664704
| Article | Year |
|---|---|
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication | 2022 |
4 other study(ies) available for sb 203580 and nsc 664704
| Article | Year |
|---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |